Abstract:Luteolin was recently demonstrated to suppress tumor growth by interfering with nuclear factor (NF)‑κB activation. As the NF‑κB pathway plays a critical role in muscular atrophy associated with cancer cachexia, we aimed to investigate the potential of luteolin to alleviate cancer‑associated cachexia in a Lewis lung cancer mouse model. C57BL/6 mice were divided into three groups: A control group, a model group and a luteolin group. Mice in the model and luteolin groups received a subcutaneous injection of Lewis lung cancer cells, while the control group received PBS. Subsequently, the tumor mass, serum, gastrocnemius muscle and heart were collected on day 21. The serum, gastrocnemius muscle and heart were weighed and prepared for use in enzyme‑linked immunosorbent assay (ELISA), western blotting (WB) and quantitative reverse transcription polymerase chain reaction (qRT‑PCR) analyses. The results revealed that the tumor‑free body mass was significantly reduced in tumor‑bearing mice compared with that of mice in the other groups. The gastrocnemius muscle mass and heart mass were greater in the luteolin treatment group than in the control group. Tumor necrosis factor (TNF)‑α and interleukin (IL)‑6 levels were lower in the luteolin treatment group than in the model group. In addition, according to the results of the WB and qRT‑PCR analyses, the expression of the E3 ubiquitin ligase muscle RING finger‑containing protein 1 (MuRF1) was downregulated in skeletal muscle and cardiac muscle, whereas atrogin‑1 was downregulated only in skeletal muscle in the luteolin treatment group vs. the model group. Furthermore, IκB kinase β (IKKβ) and phospho‑p65 were significantly downregulated in skeletal muscle and cardiac tissue, whereas the expression of p‑p38 was downregulated only in skeletal muscle in the luteolin treatment group when compared with their expression levels in the model group, as determined by the WB analysis. In conclusion, from the current results, we conclude that luteolin is able to reduce inflammatory burden, downregulate the expression of genes associated with muscle protein breakdown, and protect skeletal and heart muscle from cancer‑induced wasting and loss in vivo. Therefore, luteolin has the potential to be developed into a novel anti‑cachetic agent.

Luteolin alleviates muscle atrophy, mitochondrial dysfunction and abnormal FNDC5 expression in high fat diet-induced obese rats and palmitic acid-treated C2C12 myotubes

Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice

LUTEOLIN REDUCES CARDIAC DYSFUNCTIONS AND MITOCHONDRIAL OXIDATIVE STRESS IN STREPTOZOTOCIN‐INDUCED DIABETIC RATS

Luteolin Reduces Cancer‑induced Skeletal and Cardiac Muscle Atrophy in a Lewis Lung Cancer Mouse Model.

Lutein Attenuates Excessive Lipid Accumulation in Differentiated 3T3-L1 Cells and Abdominal Adipose Tissue of Rats by the SIRT1-mediated Pathway.

Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity

Lactiplantibacillus Plantarum Fermented Barley Extracts Ameliorate High-Fat-diet-induced Muscle Dysfunction Via Mitophagy

Luteolin Protects Against High Fat Diet-Induced Cognitive Deficits in Obesity Mice.

Luteolin ameliorates palmitate-induced lipotoxicity in hepatocytes by mediating endoplasmic reticulum stress and autophagy

Luteolin Ameliorates Hepatic Steatosis and Enhances Mitochondrial Biogenesis Via AMPK/PGC-1α Pathway in Western Diet-Fed Mice.

Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity

L-Arginine Alleviates LPS-Induced Oxidative Stress and Apoptosis Via Activating SIRT1-AKT-Nrf2 and SIRT1-FOXO3a Signaling Pathways in C2C12 Myotube Cells

Diet Supplementation of Luteolin Before Fatty Liver Formation Improves Hepatic Steatosis in Obese Mice by Inhibiting Visceral Adipose Tissue Lipolysis.

Ameliorative Effects of Lutein on Non-Alcoholic Fatty Liver Disease in Rats

Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages

Nutritional activities of luteolin in obesity and associated metabolic diseases: an eye on adipose tissues

Effects of lycopene on skeletal muscle-fiber type and high-fat diet-induced oxidative stress

Luteolin Improves Myocardial Cell Glucolipid Metabolism by Inhibiting Hypoxia Inducible Factor-1Α Expression in Angiotensin II/hypoxia-induced Hypertrophic H9c2 Cells.

Luteolin Alleviates Diabetic Nephropathy Fibrosis Involving AMPK/NLRP3/TGF-β Pathway

Luteolin Inhibits Obesity-Associated Adipose Tissue Macrophage Polarization through Protein Kinase C(PKC) Pathway

Lonicera caerulea Berry Polyphenols Extract Alleviates Exercise Fatigue in Mice by Reducing Oxidative Stress, Inflammation, Skeletal Muscle Cell Apoptosis, and by Increasing Cell Proliferation